Investors

Financial Communications Schedule for the Second Half of 2019

28 June 2019, Sophia Antipolis, France

Press Release – For immediate release – 5:45 PM CEST

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company®, announces the publication date for its half year results 2019:

Publication Date
2019 half year results October 3, 2019*

* Distribution after the close of trading

About Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment strategies. Our unique solutions for medical image analysis and management in oncology trials and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT).

Contacts

Median Technologies

Emmanuelle Leygues
Head of Corporate Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Actifin  (Investors)

Ghislaine Gasparetto
+33 1 56 88 11 11
ggasparetto@actifin.fr

Alizé RP  (Press)

Caroline Carmagnol
Aurore Gangloff
+33 6 49 57 82 68
median@alizerp.com

Cookies help us deliver our services. By using our services, you agree to our use of cookies.